Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Reportlinker Adds PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years

June 15, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 15, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years...

Reportlinker Adds Global Medical Equipment Rental and Leasing Industry

June 15, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 15, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Medical Equipment Rental and Leasing Industry...

Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011

June 15, 2011 1:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 15, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011...

Advertisement

Landmark report reveals immense burden of osteoporotic fractures in Europe

June 15, 2011 1:33 am | by International Osteoporosis Foundation | News | Comments

Economic burden of fractures in Europe far higher than previously estimated; fractures result in more costs and disability than many other common chronic diseases

MGT Capital Investments Receives NYSE Amex Listing Deficiency Notification

June 14, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

LONDON, June 14, 2011 /- MGT Capital Investments, Inc. (NYSE Amex: MGT ), today announced that on June 8, 2011 it received notice from the NYSE Amex (the "Exchange") notifying the Company it is not in compliance with following Exchange continued listing standards:  Section 1003(a)(i)...

MigreLief Now On Lifetime T.V.'s "The Balancing Act" Airing June 20th & July 25th

June 14, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, June 14, 2011 /- The makers of MigreLief , the world's most successful patented natural migraine prevention therapy, can now be seen on the popular nationally broadcast Lifetime series, " The Balancing Act." On June 20th and again on July 25th, (7:00 a.m. et/pt) this...

Scientists Image Beginning Stages of Ovarian Cancer Growth with Time Lapse Technique

June 14, 2011 10:34 am | by AACR | News | Comments

Tweet • New model of time-lapse microscopy provides better visualization of metastatic processes. • Knowledge could allow for therapeutic targeting to prevent metastasis. • NOTE TO PRODUCERS/EDITORS: Video footage available. PHILADELPHIA - Scientists at Harvard University have created a...

Boston Scientific iCross and Atlantis SR Pro 2 Coronary Imaging Catheters: Recall – Catheter Tip Can Break Inside of the Patient

June 14, 2011 10:30 am | by U.S. Food & Drug Administration | News | Comments

Risk of embolization causing tissue and blood vessel injury, heart attack or other serious events.

Advertisement

FDA Approves First Ceramic-on-Metal Total Hip Replacement System

June 14, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved on June 13 the first ceramic-on-metal total artificial hip system for patients with osteoarthritis. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Hip joints...

Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT®

June 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

RICHMOND, Texas, June 14, 2011 /- OCuSOFT, Inc., an ophthalmic pharmaceutical research, development and supply company today announced an exclusive multiyear agreement with Ardeo Health, LLC to distribute a novel dry eye therapy under license from Novagali Pharma S.A. of Evry, France,...

Theramed Corporation to Launch Glenveigh Products, ebbâ„¢ and jettyâ„¢ at the Society of Obstetricians and Gynecologists of Canada

June 14, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, June 14, 2011 /- Theramed Corporation ("Theramed") announces that it will launch ebb™ and jetty™ at the 67th Clinical Meeting of the Society of Obstetricians and Gynecologists of Canada. The two newly developed medical devices are to be used to advance...

Flexible Endoscope Manufacturer Determines Test Suitable for Evaluating Cleanliness of Flexible Endoscopes

June 14, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

FRASER, Mich., June 14, 2011 /- At the 2011 Society of Gastroenterology Nurses and Associates (SGNA) Convention held in Indianapolis, IN, Olympus America, Inc. (Allentown, PA) presented the results of a study evaluating the effectiveness of a 3-1 test strip for detecting residual organic...

Incidence of Gastrointestinal Disorders in Patients With Parkinson's Disease Increased Over Time and Impacted Clinical and Health Economic Outcomes

June 14, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

BRUSSELS, June 14, 2011 /- A new study investigating the incidence and impact of gastrointestinal disorders (GID) among patients with Parkinson's disease (PD) found that patients who received both a PD diagnosis and a prior GID diagnosis appeared to have worse health outcomes compared to...

Advertisement

FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment

June 14, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a...

Maquet Datascope Corp. Intra-Aortic Balloon Pumps: Recall – Shuts Off Without Warning

June 14, 2011 9:31 am | by U.S. Food & Drug Administration | News | Comments

Consequences may include the inability to decrease already-present ischemia, thrombus formation, organ injury or other serious events.

Terumo Coronary Ostia Cannula 10, 12, 14 Fr: Recall – Fragments of Adhesive and Plastic in the Cannula Tip May Embolize

June 14, 2011 9:30 am | by U.S. Food & Drug Administration | News | Comments

Risk of arterial injury, hemorrhaging, or other serious events.

Class I Medical Device Recall: Terumo Coronary Ostia Cannula 10, 12, 14 Fr

June 14, 2011 8:32 am | by U.S. Food & Drug Administration | News | Comments

Reason for Recall: Foreign fragments of adhesive and plastic in the cannula tip may embolize causing arterial injury, hemorrhaging or other serious events requiring unplanned surgery.

Class I Medical Device Recall: Maquet Datascope Corp. Intra-Aortic Balloon Pumps

June 14, 2011 8:31 am | by U.S. Food & Drug Administration | News | Comments

Reason for Recall: A defective fan in the power supply may cause overheating and shut down the device without visible or audible alarms. Consequences of unanticipated interruption of therapy may include the inability to decrease already-present ischemia..

ANF Group, Inc. Completes New Joe DiMaggio Children's Hospital

June 14, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

FORT LAUDERDALE, Fla., June 14, 2011 /- ANF Group, Inc ., a South Florida based construction management firm, announced today the completion of the 170,000-square-foot Joe DiMaggio Children's Hospital – the first free standing children's hospital in Broward County. (Photo:...

ImpactRx Expands Psychiatry Research Panel to Include Adolescent Psychiatrists

June 14, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

MOUNT LAUREL, N.J., June 14, 2011 /- ImpactRx, the pioneer in measuring the impact of promotion on physician prescribing behavior announced today that it has expanded its nationwide network of high-value, iPhone-connected physicians.  ImpactRx now has access to 175 adult...

Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia

June 14, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

AUGUSTA, Ga., June 14, 2011 /- Cardinal Health today opened its first cyclotron facility in the state of Georgia, further expanding its nationwide capability to manufacture molecular imaging biomarkers that aid in the early diagnosis, monitoring and treatment of cancer, neurological...

Lilly for Better Healthâ„¢ Launches Enhanced Multi-Channel Patient Education Platform

June 14, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 14, 2011 /- Lilly for Better Health ™, a program of Lilly USA, LLC, (NYSE: LLY ) that helps Americans live healthier, more active lives, launches an enhanced multi-channel platform designed to reach patients where they like to receive health information. The...

Low-Carbohydrate, High-Protein Diets May Reduce Both Tumor Growth Rates and Cancer Risk

June 14, 2011 6:33 am | by AACR | News | Comments

Tweet   • Laboratory study has clear implications for humans. • Low carbohydrates reduce blood glucose, which tumor cells need.• Possible anti-inflammatory effect also observed. PHILADELPHIA — Eating a low-carbohydrate, high-protein diet...

Vinomis Laboratories Launches Vindurance Challenge to Substantiate Claims of Enhanced Physical Endurance with Use of Resveratrol and Quercetin

June 14, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SEWICKLEY, Pa., June 14, 2011 /- The benefits of resveratrol are well studied and documented in controlled scientific studies.  It has been shown to slow down the aging process and help prevent age-related diseases including heart disease, cancer, Alzheimer's, diabetes, and others....

Pacira Pharmaceuticals, Inc. Announces FDA Extension of EXPARELâ„¢ PDUFA Target Date by Three Months

June 14, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., June 14, 2011 /- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading